Loading clinical trials...
Loading clinical trials...
A Phase II Study to Investigate Mannitol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD
Conditions
Interventions
Dry powder mannitol
Budesonide 400mcg administered via turbuhaler
+2 more
Locations
13
Australia
Respiratory Clinic
Sydney, New South Wales, Australia
Peninsula Medical Centre
Umina, New South Wales, Australia
Wesley Medical Centre
Auchenflower, Queensland, Australia
Brisbane South Clinical Clinical Research Centre
Brisbane, Queensland, Australia
Inala Health Centre
PO BOx 52, Inala, Queensland, Australia
Flinders University
Bedford Park, South Australia, Australia
Start Date
July 1, 2005
Completion Date
August 1, 2006
Last Updated
April 20, 2016
NCT06385301
NCT05399082
NCT06306482
NCT05029557
NCT00159341
NCT04088942
Lead Sponsor
Syntara
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions